These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
623 related articles for article (PubMed ID: 33771086)
21. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future. Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749 [TBL] [Abstract][Full Text] [Related]
22. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864 [TBL] [Abstract][Full Text] [Related]
23. Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease. Scharrer S; Kutschera M; Weseslindtner L; Primas C; Vogelsang H Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):443-447. PubMed ID: 33522752 [TBL] [Abstract][Full Text] [Related]
24. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician. Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370 [TBL] [Abstract][Full Text] [Related]
25. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations. Bekic D; Belosic Halle Z Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405 [TBL] [Abstract][Full Text] [Related]
26. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers. Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T; Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052 [TBL] [Abstract][Full Text] [Related]
27. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey. Nakase H; Wagatsuma K; Nojima M; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Takeuchi K; Tamura S; Kinjo F; Ueno N; Naganuma M; Watanabe K; Moroi R; Nishimata N; Motoya S; Kurahara K; Takahashi S; Maemoto A; Sakuraba H; Saruta M; Tominaga K; Hisabe T; Tanaka H; Terai S; Hiraoka S; Takedomi H; Narimatsu K; Endo K; Nakamura M; Hisamatsu T J Gastroenterol; 2023 Mar; 58(3):205-216. PubMed ID: 36607399 [TBL] [Abstract][Full Text] [Related]
28. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients. Azzam NA; Aljebreen A; Almuhareb A; Almadi MA Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045 [TBL] [Abstract][Full Text] [Related]
29. Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia. Massuger W; Moore GTC; Andrews JM; Kilkenny MF; Reyneke M; Knowles S; Purcell L; Alex G; Buckton S; Page AT; Stocks N; Cameron D; Manglaviti F; Pavli P Intern Med J; 2019 Jul; 49(7):859-866. PubMed ID: 30525299 [TBL] [Abstract][Full Text] [Related]
30. A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy. Di Ruscio M; Lunardi G; Buonfrate D; Gobbi F; Bertoli G; Piccoli D; Conti A; Geccherle A; Variola A Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684085 [No Abstract] [Full Text] [Related]
31. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic. El Ouali S; Rubin DT; Cohen BL; Regueiro MD; Rieder F Curr Opin Gastroenterol; 2021 Jul; 37(4):313-319. PubMed ID: 33859104 [TBL] [Abstract][Full Text] [Related]
32. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry. Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168 [TBL] [Abstract][Full Text] [Related]
33. High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study. Baars JE; Zelinkova Z; Mensink PB; Markus T; Looman CW; Kuipers EJ; Van Der Woude CJ Aliment Pharmacol Ther; 2009 Oct; 30(8):864-72. PubMed ID: 19706149 [TBL] [Abstract][Full Text] [Related]
34. Inflammatory Bowel Disease Patients' Perspectives during COVID-19 Pandemic: Results from a Portuguese Survey. Revés JB; Frias-Gomes C; Morão B; Nascimento C; Palmela C; Fidalgo C; Roque Ramos L; Sampaio A; Glória L; Cravo M; Torres J GE Port J Gastroenterol; 2021 Sep; 5(5):1-9. PubMed ID: 34934777 [TBL] [Abstract][Full Text] [Related]
35. Effects of SARS-CoV-2 vaccine (Vero cells) on disease activity in patients with inflammatory bowel disease in China: a multicenter study. Zhang M; Huang Q; Shi C; Feng Y; Duan T; Lin T; Zhu Y; Liu G; Li H; Liu Y; Jiang B Int J Colorectal Dis; 2023 Feb; 38(1):31. PubMed ID: 36757427 [TBL] [Abstract][Full Text] [Related]
36. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective. Grunert PC; Reuken PA; Stallhofer J; Teich N; Stallmach A J Crohns Colitis; 2020 Dec; 14(12):1702-1708. PubMed ID: 32564068 [TBL] [Abstract][Full Text] [Related]
37. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report. Rieker L; Hofer J; Petzold G; Ellenrieder V; Amanzada A BMC Gastroenterol; 2022 Jan; 22(1):22. PubMed ID: 35033015 [TBL] [Abstract][Full Text] [Related]
38. Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients' behavior. Dorfman L; Nassar R; Binjamin Ohana D; Oseran I; Matar M; Shamir R; Assa A Pediatr Res; 2021 Sep; 90(3):637-641. PubMed ID: 33446913 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451 [TBL] [Abstract][Full Text] [Related]
40. Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease. Wetwittayakhlang P; Albader F; Golovics PA; Hahn GD; Bessissow T; Bitton A; Afif W; Wild G; Lakatos PL Can J Gastroenterol Hepatol; 2021; 2021():7591141. PubMed ID: 34858891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]